Thrombosis of the corpora cavernosa complicating lenalidomide therapy of myelofibrosis

详细信息    查看全文

• 作者：Fuad A. El Rassi ; Constantine S. Tam ; John Carwile ; Srdan Verstovsek
• 关键词：Coagulation ; Agnogenic myeloid metaplasia ; Immunomodulary drug
• 刊名：Leukemia Research
• 出版年：2008
• 出版时间：May 2008
• 年：2008
• 卷：32
• 期：5
• 页码：821-822
• 全文大小：71 K

文摘

Venous thrombosis is a well-recognized complication of lenalidomide therapy in patients with multiple myeloma, but its occurrence during the treatment of other hematologic malignancies is less well described. In this report, we detail the occurrence of corpora cavernosa thrombosis in a patient receiving lenalidomide for the therapy of myelofibrosis. This case highlights the need for clinical vigilance in patients who present with unusual symptoms during investigational therapy, and indicates that the occurrence of venous thrombosis complicating therapy with lenalidomide or related compounds is not isolated to patients with multiple myeloma.